UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
ALPS Sector Dividend Dogs ETF
SDOG
$1.41B
| $19.4M | ﹤0.01% |
367,908
-42,654
| -10% | -$2.26M |
|
1702
American Financial Group
AFG
$12.2B
| $19.4M | ﹤0.01% |
157,993
+26,491
| +20% | +$3.41M |
|
1703
CALL
Halliburton
HAL
$27.1B
| $19.4M | ﹤0.01% |
574,800
+188,100
| +49% | +$6.94M |
|
1704
Invesco S&P SmallCap 600 Revenue ETF
RWJ
$2.09B
| $19.4M | ﹤0.01% |
484,368
-22,506
| -4% | -$920K |
|
1705
CAVA Group
CAVA
$7.25B
| $19.4M | ﹤0.01% |
209,172
+117,527
| +128% | +$9.07M |
|
1706
CALL
Moderna
MRNA
$21.5B
| $19.4M | ﹤0.01% |
163,200
-52,900
| -24% | -$6.69M |
|
|
GTLS
1707
DELISTED
Chart Industries
GTLS
| $19.4M | ﹤0.01% |
134,160
-31,739
| -19% | -$4.79M |
|
1708
CALL
Criteo S.A. Ordinary Shares
CRTO
$883M
| $19.4M | ﹤0.01% |
513,100
+498,300
| +3,367% | +$18.2M |
|
1709
Flowserve
FLS
$10B
| $19.3M | ﹤0.01% |
401,874
-68,950
| -15% | -$3.3M |
|
1710
Invesco Ultra Short Duration ETF
GSY
$3.9B
| $19.3M | ﹤0.01% |
386,681
-24,398
| -6% | -$1.22M |
|
|
1711
Criteo S.A. Ordinary Shares
CRTO
$883M
| $19.3M | ﹤0.01% |
511,168
+408,743
| +399% | +$15M |
|
1712
CALL
Century Aluminum
CENX
$4.55B
| $19.3M | ﹤0.01% |
+1,150,462
| New | +$19.6M |
|
1713
Whirlpool
WHR
$2.8B
| $19.3M | ﹤0.01% |
188,372
-1,525
| -0.8% | -$149K |
|
1714
Columbia EM Core ex-China ETF
XCEM
$1.97B
| $19.2M | ﹤0.01% |
602,375
+33,644
| +6% | +$1.04M |
|
|
CNH
1715
CNH Industrial
CNH
$17.4B
| $19.2M | ﹤0.01% |
1,895,146
-181,938
| -9% | -$2.06M |
|
1716
News Corp Class A
NWSA
$16.1B
| $19.2M | ﹤0.01% |
695,117
+156,315
| +29% | +$4.04M |
|
1717
Houlihan Lokey
HLI
$8.92B
| $19.1M | ﹤0.01% |
141,974
-14,923
| -10% | -$1.95M |
|
1718
Pembina Pipeline
PBA
$27.9B
| $19.1M | ﹤0.01% |
514,833
+119,723
| +30% | +$4.33M |
|
1719
First Trust Indxx NextG ETF
NXTG
$556M
| $19.1M | ﹤0.01% |
232,853
-11,144
| -5% | -$875K |
|
1720
Independence Realty Trust
IRT
$4B
| $19.1M | ﹤0.01% |
1,017,616
+584,960
| +135% | +$9.78M |
|
1721
iShares iBonds Dec 2030 Term Corporate ETF
IBDV
$3.28B
| $19.1M | ﹤0.01% |
896,099
-932,831
| -51% | -$19.7M |
|
1722
Viking Therapeutics
VKTX
$3.88B
| $19.1M | ﹤0.01% |
359,382
+85,326
| +31% | +$5.59M |
|
1723
Sight Sciences
SGHT
$386M
| $19M | ﹤0.01% |
2,855,850
-15,914
| -0.6% | -$94.1K |
|
1724
Paycom
PAYC
$10.1B
| $19M | ﹤0.01% |
133,168
+50,940
| +62% | +$8.73M |
|
1725
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$42.4B
| $19M | ﹤0.01% |
130,500
-555,900
| -81% | -$79.7M |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.